163 related articles for article (PubMed ID: 3105446)
1. Pharmacokinetics and tissue penetration of Ro 23-6240, a new trifluoroquinolone.
Wise R; Kirkpatrick B; Ashby J; Griggs DJ
Antimicrob Agents Chemother; 1987 Feb; 31(2):161-3. PubMed ID: 3105446
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and tissue penetration of ciprofloxacin.
Crump B; Wise R; Dent J
Antimicrob Agents Chemother; 1983 Nov; 24(5):784-6. PubMed ID: 6660852
[TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetics and tissue penetration of norfloxacin.
Adhami ZN; Wise R; Weston D; Crump B
J Antimicrob Chemother; 1984 Jan; 13(1):87-92. PubMed ID: 6230344
[TBL] [Abstract][Full Text] [Related]
4. Single- and multiple-dose pharmacokinetics of fleroxacin, a trifluorinated quinolone, in humans.
Weidekamm E; Portmann R; Suter K; Partos C; Dell D; Lücker PW
Antimicrob Agents Chemother; 1987 Dec; 31(12):1909-14. PubMed ID: 3125788
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tissue penetration of enoxacin.
Wise R; Lockley R; Dent J; Webberly M
Antimicrob Agents Chemother; 1984 Jul; 26(1):17-9. PubMed ID: 6591851
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and inflammatory fluid penetration of sparfloxacin.
Johnson JH; Cooper MA; Andrews JM; Wise R
Antimicrob Agents Chemother; 1992 Nov; 36(11):2444-6. PubMed ID: 1336947
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and tissue penetration of orally administered pefloxacin.
Webberley JM; Andrews JM; Ashby JP; McLeod A; Wise R
Eur J Clin Microbiol; 1987 Oct; 6(5):521-4. PubMed ID: 3481335
[TBL] [Abstract][Full Text] [Related]
8. The metabolism and pharmacokinetics of fleroxacin in healthy subjects.
Griggs DJ; Wise R; Kirkpatrick B; Ashby JP
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():191-4. PubMed ID: 3144537
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of Ro 23-6240 (AM 833), a new trifluorinated quinolone.
Weidekamm E; Stöckel K; Dell D
Chemioterapia; 1987 Jun; 6(2 Suppl):307-8. PubMed ID: 3151346
[No Abstract] [Full Text] [Related]
10. The pharmacokinetics and tissue penetration of ofloxacin.
Lockley MR; Wise R; Dent J
J Antimicrob Chemother; 1984 Dec; 14(6):647-52. PubMed ID: 6596301
[TBL] [Abstract][Full Text] [Related]
11. Single and multiple dose pharmacokinetics of fleroxacin.
Weidekamm E; Portmann R; Partos C; Dell D
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():145-54. PubMed ID: 3144533
[TBL] [Abstract][Full Text] [Related]
12. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
Nye K; Shi YG; Andrews JM; Ashby JP; Wise R
J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
[TBL] [Abstract][Full Text] [Related]
13. The pharmacokinetics and inflammatory fluid penetration of orally administered azithromycin.
Cooper MA; Nye K; Andrews JM; Wise R
J Antimicrob Chemother; 1990 Oct; 26(4):533-8. PubMed ID: 2174853
[TBL] [Abstract][Full Text] [Related]
14. A new trifluorinated quinolone: Ro 23-6240 (AM 833).
Weidekamm E; Stöckel K; Dell D
Drugs Exp Clin Res; 1987; 13(2):85-90. PubMed ID: 3107959
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tissue penetration of fleroxacin after single and multiple 400- and 800-mg-dosage regimens.
Panneton AC; Bergeron MG; LeBel M
Antimicrob Agents Chemother; 1988 Oct; 32(10):1515-20. PubMed ID: 3142338
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
Wise R; Mortiboy D; Child J; Andrews JM
Antimicrob Agents Chemother; 1996 Jan; 40(1):47-9. PubMed ID: 8787877
[TBL] [Abstract][Full Text] [Related]
17. Open-label crossover study to determine pharmacokinetics and penetration of two dose regimens of levofloxacin into inflammatory fluid.
Child J; Mortiboy D; Andrews JM; Chow AT; Wise R
Antimicrob Agents Chemother; 1995 Dec; 39(12):2749-51. PubMed ID: 8593013
[TBL] [Abstract][Full Text] [Related]
18. A study to determine the pharmacokinetics and inflammatory fluid penetration of gatifloxacin following a single oral dose.
Wise R; Andrews JM; Ashby JP; Marshall J
J Antimicrob Chemother; 1999 Nov; 44(5):701-4. PubMed ID: 10552990
[TBL] [Abstract][Full Text] [Related]
19. Penetration of fleroxacin and ciprofloxacin into skin blister fluid: a comparative study.
Lubowski TJ; Nightingale C; Sweeney K; Quintiliani R; Zhi J
Antimicrob Agents Chemother; 1992 Mar; 36(3):651-5. PubMed ID: 1622179
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and tissue penetration of orally administered lomefloxacin.
Stone JW; Andrews JM; Ashby JP; Griggs D; Wise R
Antimicrob Agents Chemother; 1988 Oct; 32(10):1508-10. PubMed ID: 3190181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
